Profile
Hélène Sabatel currently works at DeuterOncology SA, as Director and Noshaq SA, as Investment Manager.
Hélène Sabatel active positions
| Companies | Position | Start |
|---|---|---|
DeuterOncology SA
DeuterOncology SA BiotechnologyHealth Technology Operates as a preclinical-stage biotechnology company which focuses on the development of first-in-class dual MET and RAS pathway inhibitor for targeted cancer therapies | Director/Board Member | - |
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an active manager which invests in companies located in Belgium with a focus on the Liège area. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed stage, early stage, later stage and growth stage. | Private Equity Investor | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an active manager which invests in companies located in Belgium with a focus on the Liège area. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed stage, early stage, later stage and growth stage. | Finance |
DeuterOncology SA
DeuterOncology SA BiotechnologyHealth Technology Operates as a preclinical-stage biotechnology company which focuses on the development of first-in-class dual MET and RAS pathway inhibitor for targeted cancer therapies | Health Technology |
- Stock Market
- Insiders
- Hélène Sabatel
















